From January 9, 2023 to March 31, 2023, the company has repurchased 12,096,900 shares, representing 0.87% for CNY 100.01 million. With this, the company has completed the repurchase of 12,096,900 shares, representing 0.87% for CNY 100.01 million under the buyback announced on January 9, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.11 CNY | -2.84% | -12.37% | -49.32% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-49.32% | 780M | |
+38.28% | 6.07B | |
-16.91% | 4.42B | |
+5.14% | 3.26B | |
-14.63% | 3B | |
-4.12% | 2.47B | |
+42.14% | 1.89B | |
-10.63% | 1.63B | |
-2.71% | 1.6B | |
-12.26% | 1.54B |
- Stock Market
- Equities
- 002424 Stock
- News Guizhou Bailing Group Pharmaceutical Co., Ltd.
- Tranche Update on Guizhou Bailing Group Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 9, 2023.